Popular Posts
-
The U.S. Food and Drug Administration today announced plans to hold a public meeting on July 19-20, 2010, to discuss how the agency will ov... -
AGA Medical today announced first patient enrollment in the feasibility phase of the prospective, multicenter, randomized AMPLATZER(R) Card... -
22nd Century Group Inc., a company focused on smoking cessation and tobacco harm reduction products, announced X-22, a prescription smo... -
A preliminary study has found that a targeted treatment for medulloblastoma -- the most common malignant brain cancer in children -- may o...
-
The U.S. Food and Drug Administration today approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at...
-
CorMedix Inc. ("CorMedix") , a pharmaceutical company focused on developing and commercializing therapeutic products for the p... -
GE Healthcare, a provider of medical technologies and services, has received the FDA approval for Cysview , which is used for the detection ...
-
The Government may soon ban the controversial anti-anxiety drug Deanxit, a combination of two psycho-active agents being frequently pr... -
To, The Editor, Clinical Research News Sir, I am writing this letter in connection with the recent ban of human placenta extract as a drug ...
-
Patients can heave a sigh of relief. A new diagnostic test kit can now detect symptoms of critical infections very quickly -- in seven...
